HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

Samarium Sm-153 Lexidronam

HCID 76962714
New reaction
Print
Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
122575-21-7
Standard SMILES
O=P([O-])(O)CN(CCN(CP(=O)([O-])O)CP(=O)(O)O)CP(=O)([O-])O.[153Sm+3]
InChIKey
JSTADIGKFYFAIY-GJNDDOAHSA-K
Molecular formula
C6H17N2O12P4Sm
Average molar mass
586.02 g/mol
Monoisotopic mass
585.8953

Overview

Samarium Sm 153 lexidronam is a radioactive medication used to treat pain caused by cancer that has spread to the bone. It is a radiopharmaceutical. Radiopharmaceuticals are radioactive agents that may be used to diagnose some diseases by studying the function of the body's organs or to treat certain diseases.Samarium Sm 153 lexidronam is used to help relieve the bone pain that may occur with certain kinds of cancer. The radioactive samarium is taken up in the bone cancer area and gives off radiation that helps provide relief of pain.

Names & identifiers

Preferred name
Samarium Sm-153 Lexidronam
IUPAC
[2-[bis[[hydroxy(oxido)phosphoryl]methyl]amino]ethyl-(phosphonomethyl)amino]methyl-hydroxyphosphinate;samarium-153(3+)

Names & synonyms

153Sm-EdtmpSamarium (153Sm) lexidronamSamarium sm-153 lexidronamSamarium-153 lexidronamSAMARIUM (153 SM) LEXIDRONAMSamarium-153-edtmp745X144DZYSAMARIUM, SM-153 LEXIDRONAMSm-Edtmp122575-21-7DTXSID40894187Samarium-153 EDTMP
Show more names
RefChem:884513Samarium Sm-153 EDTMPSm-153 EDTMPsamario (153Sm) lexidronamsamarii (153Sm) lexidronamumV10BX02DTXCID401324231Samarium-153 Ethylenediaminetetramethylenephosphonate

Database identifiers

CAS
122575-21-7
PubChem CID
76962714
UNII
745X144DZY

Properties

Computed structural properties

Topological polar surface area
245 Ų
Hydrogen bond donors
5
Hydrogen bond acceptors
14
Rotatable bonds
11
Heavy atoms
25
Formal charge
0
Complexity
556

Experimental & physicochemical properties

Human DrugsBreast Feeding; Lactation; Radiopharmaceuticals; Samarium Radioisotopes

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

Toxicology

Effects During Pregnancy and Lactation◉ Summary of Use during Lactation

Chemistry & industry

Pharmacology

ATC Code · 2 items

V - Various

QV - Various

Mechanism of Action · 1 item

Samarium Sm 153 lexidronam targets the sites of new bone formation, concentrating in regions of the bone that have been invaded with metastatic tumor. The drug goes to the source of cancer bone pain and irradiates the osteoblastic tumor sites resulting in relief of pain. The onset of pain relief was experienced as early as one week in the majority of patients.

MeSH Pharmacological ClassificationA subclass of analgesic agents that typically do not bind to OPIOID RECEPTORS and are not addictive. Many non-narcotic analgesics are offered as NONPRESCRIPTION DRUGS.

Related reactions

0 records
New reaction record
No related reactions yet

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes